This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Aug;114(2):371; author reply 371-2.

doi: 10.1016/j.ygyno.2009.03.037. Epub 2009 Apr 29.

Is randomized trial of neoadjuvant chemotherapy of ovarian cancer necessary?

PMID: 19403162
DOI: 10.1016/j.ygyno.2009.03.037

Comment

Is randomized trial of neoadjuvant chemotherapy of ovarian cancer necessary?

Chinmoy K Bose. Gynecol Oncol. 2009 Aug.

. 2009 Aug;114(2):371; author reply 371-2.

doi: 10.1016/j.ygyno.2009.03.037. Epub 2009 Apr 29.

Author

PMID: 19403162
DOI: 10.1016/j.ygyno.2009.03.037

No abstract available

PubMed Disclaimer

Comment on

Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
Onda T, Kobayashi H, Nakanishi T, Hatae M, Iwasaka T, Konishi I, Shibata T, Fukuda H, Kamura T, Yoshikawa H. Onda T, et al. Gynecol Oncol. 2009 Apr;113(1):57-62. doi: 10.1016/j.ygyno.2008.12.027. Epub 2009 Jan 31. Gynecol Oncol. 2009. PMID: 19181369 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information